Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS: KBLB · Delayed Price · USD
0.0918
-0.0023 (-2.39%)
Apr 26, 2024, 3:58 PM EDT - Market closed
KBLB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.55 | 3.86 | 2.36 | 0.82 | 0.13 | 0.01 | 0.02 | 0.3 | 0.24 | 0.5 | Upgrade
|
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 2.55 | 3.86 | 2.36 | 0.82 | 0.13 | 0.01 | 0.02 | 0.3 | 0.24 | 0.5 | Upgrade
|
| Cash Growth | -33.94% | 64.02% | 188.29% | 553.40% | 812.78% | -24.53% | -93.93% | 25.47% | -51.88% | 67.59% | Upgrade
|
| Receivables | 0 | -0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 | 0 | 0 | Upgrade
|
| Inventory | 0.01 | 0.01 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 0.01 | 0.11 | 0.01 | 0 | 0.03 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Current Assets | 2.57 | 3.98 | 2.37 | 0.82 | 0.16 | 0.02 | 0.05 | 0.33 | 0.24 | 0.5 | Upgrade
|
| Property, Plant & Equipment | 0.16 | 0.15 | 0.22 | 0.45 | 0.59 | 0.05 | 0.06 | 0.05 | 0.07 | 0.04 | Upgrade
|
| Long-Term Investments | 0.49 | 0.44 | 0.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Long-Term Assets | 0.66 | 0.59 | 0.66 | 0.46 | 0.59 | 0.05 | 0.07 | 0.05 | 0.07 | 0.04 | Upgrade
|
| Total Assets | 3.23 | 4.57 | 3.02 | 1.28 | 0.75 | 0.07 | 0.11 | 0.38 | 0.3 | 0.54 | Upgrade
|
| Accounts Payable | 0.93 | 0.54 | 5.83 | 5.4 | 4.71 | 4.14 | 3.35 | 2.63 | 2.14 | 1.7 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | -4.14 | -3.35 | -2.63 | -0.07 | 0 | Upgrade
|
| Current Debt | 1.76 | 1.75 | 2.27 | 1.98 | 0.81 | 0.32 | 0.08 | 0.05 | 0.07 | 0 | Upgrade
|
| Other Current Liabilities | 6.2 | 5.78 | 0.07 | 0.07 | 0.07 | 4.21 | 3.41 | 2.69 | 0.07 | 0.06 | Upgrade
|
| Total Current Liabilities | 8.89 | 8.07 | 8.16 | 7.45 | 5.58 | 4.53 | 3.49 | 2.74 | 2.2 | 1.76 | Upgrade
|
| Long-Term Debt | 0.05 | 0.02 | 0.16 | 0.4 | 0.55 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Long-Term Liabilities | 0.05 | 0.02 | 0.16 | 0.4 | 0.55 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Liabilities | 8.94 | 8.09 | 8.32 | 7.85 | 6.14 | 4.53 | 3.49 | 2.74 | 2.2 | 1.76 | Upgrade
|
| Total Debt | 1.81 | 1.77 | 2.42 | 2.38 | 1.37 | 0.32 | 0.08 | 0.05 | 0.07 | 0 | Upgrade
|
| Debt Growth | 2.34% | -26.78% | 1.58% | 74.27% | 324.60% | 302.50% | 60.00% | -23.42% | - | - | Upgrade
|
| Common Stock | 27.39 | 27.06 | 22.39 | 17.12 | 16.76 | 15.15 | 15.14 | 12.96 | 10.8 | 9.81 | Upgrade
|
| Retained Earnings | -49.69 | -46.66 | -42.81 | -34.77 | -29.8 | -26.89 | -25.72 | -23.39 | -20.31 | -18.18 | Upgrade
|
| Comprehensive Income | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.28 | 0.02 | 0.02 | Upgrade
|
| Shareholders' Equity | -5.71 | -3.52 | -5.3 | -6.57 | -5.39 | -4.46 | -3.38 | -2.36 | -1.9 | -1.23 | Upgrade
|
| Total Liabilities and Equity | 3.23 | 4.57 | 3.02 | 1.28 | 0.75 | 0.07 | 0.11 | 0.38 | 0.3 | 0.54 | Upgrade
|
| Net Cash / Debt | 0.74 | 2.09 | -0.07 | -1.57 | -1.24 | -0.31 | -0.06 | 0.25 | 0.17 | 0.5 | Upgrade
|
| Net Cash / Debt Growth | -64.69% | - | - | - | - | - | - | 43.94% | -65.07% | 69.88% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Working Capital | -6.31 | -4.09 | -5.8 | -6.63 | -5.43 | -4.51 | -3.44 | -2.41 | -1.96 | -1.27 | Upgrade
|
| Book Value Per Share | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.